Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The role of nitric oxide in sepsis and ARDS: Synopsis of a roundtable conference held in Brussels on 18–20 March 1995

  • 44 Accesses

  • 39 Citations

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Marletta MA (1993) Nitric oxide synthase structure and mechanism. J Biol Chem 268: 12231–12234

  2. 2.

    Knowles RG, Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298: 249–258

  3. 3.

    Klatt P, Heinzel B, John M, Kastner M, Bohme E, Mayer B (1992) Ca2+/ calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase. J Biol Chem 267: 11374–11378

  4. 4.

    Abu-Soud HM, Stuehr DJ (1993) Nitric oxide synthases reveal a novel role for calmodulin in controlling electron transfer. Proc Natl Acad Sci 90: 10769–10772

  5. 5.

    Heinzel B, John M, Klatt P, Bohme E, Mayer B (1992) Ca2+/calmodulindependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281: 627–630

  6. 6.

    Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM (1992) Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267: 24173–24176

  7. 7.

    Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite oxidation of sulfhydryls: the cytoxic potential of superoxide and nitric oxide. J Biol Chem 266: 4244–4250

  8. 8.

    Freeman B (1994) Free radical chemistry of nitric oxide: looking at the dark side. Chest 105: 79S-84S

  9. 9.

    Geller DA, Lowenstein C, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR (1993) Molecular cloning and expression of inducable nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci 90: 3491–3495

  10. 10.

    MacNaul KL, Hutchinson NI (1993) Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 196: 1330–1334

  11. 11.

    Robbins RA, Barnes PJ, Springall DR, Warren JB, Kwon OJ, Buttery LD, Wilson AJ, Geller DA, Polak JM (1994) Expression of inducable nitric oxide synthase in human lung epithelial cells. Biochem Biophys Res Commun 203: 209–218

  12. 12.

    Kolb JP, Paul-Eugene N, Damais C, Yamaoka K, Drapier JC, Dugas B (1994) Interleukin-4 stimulates cGMP production by IFN-y-activated human monocytes. Involvement of the nitric oxide synthase pathway. J Biol Chem 269: 9811–9816

  13. 13.

    Pietraforte D, Tritarelli E, Testa U, Minetti M (1994) gp 120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc Biol 55: 175–182

  14. 14.

    Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad HD, Hauschildt S (1994) Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol 24: 1941–1944

  15. 15.

    Schneeman M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A (1993) Nitric oxide synthase is not a constituent of the antimicrobial amrature of human mononuclear phagocytes. J Infect Dis 167: 1358–1363

  16. 16.

    Wright CD, Mülsch A, Busse R, Osswald H (1989) Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 160: 813–819

  17. 17.

    Bryant JL, Mehta P, Von der Porten A, Mehta JL (1992) Co-purification of 130 kD nitric oxide synthase and 22 kD link protein from human neutrophils. Biochem Biophys Res Commun 189: 558–564

  18. 18.

    Rao KMK, Padmanabhan J, Kilby DL, Cohen HJ, Currie MS, Weinberg JB (1992) Flow cytometric analysis of nitric oxide production in human neutrophils using dichlorofluorescein diacetate in the presence of a calmodulin inhibitor. J Leukoc Biol 51: 496–500

  19. 19.

    Schmidt HHHW, Seifert R, Bohme E (1989) Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet-activating factor and leukotriene B4. FEBS Lett 244: 357–360

  20. 20.

    Riesco A, Caramelo C, Blum G, Monton M, Gallego MJ, Casado S, Lopez Farre A (1993) Nitric oxidegenerating system as an autocrine mechanism in human polymorphonuclear leukocytes. Biochem J 292: 791–796

  21. 21.

    Yan L, Vandivier RW, Suffredini AF, Danner RL (1994) Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity. J Immunol 153: 1825–1834

  22. 22.

    Grifith MJD, Messent M, MacAllister RJ, Evans TW (1993) Aminoguanidine selectively inhibits inducable nitric oxide synthase. Br J Pharmacol 110: 963–968

  23. 23.

    Szabo C, Southan GJ, Thiemrmann C (1994) Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducable nitric oxide synthase. Proc Natl Acad Sci 91: 12472–12476

  24. 24.

    Garvey PE, Oplinger JA, Tanoury GJ, Sherman PA, Fowler M, Marshall S, Marmon MF, Paith JE, Furfine ES (1994) Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem 269: 26669–26676

  25. 25.

    Southan GJ, Szabo C, Thiemermann C (1995) Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity, Br J Pharmacol 114: 510–516

  26. 26.

    Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526

  27. 27.

    Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1984) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci 84: 9265–9269

  28. 28.

    Waldman SA, Murad F (1988) Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol 12 Suppl 5: S115-S118

  29. 29.

    Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci 88: 4651–4654

  30. 30.

    Niu X, Smith W, Kubes P (1994) Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 74: 1133–1140

  31. 31.

    Lander HM, Sehajpal P, Levine DM, Novogrodsky A (1993) Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 150: 1509–1516

  32. 32.

    Eigler A, Sinha B, Endres S (1993) Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem Biophys Res Commun 196: 494–501

  33. 33.

    van Dervort AL, Yan L, Madara PJ, Cobb JP, Wesley RA, Corriveau CC, Tropea MM, Danner RL (1994) Nitric oxide regulates endotoxin-induced TNF-α production by human neutrophils. J Immunol 152: 4102–4109

  34. 34.

    Muruganandam A, Mutus B (1994) Isolation of nitric oxide synthase from human platelets. Biochim Biophys Acta 1200: 1–6

  35. 35.

    Malinski T, Radomski MW, Taha Z, Moncada S (1993) Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Commun 194: 96–965

  36. 36.

    Lelchuk R, Radomski MW, Martin JF, Moncada S (1992) Constituitive and inducable nitric oxide synthases in human megakaryoblastic cells. J Pharmacol Exp Ther 262: 1220–1224

  37. 37.

    Mehta JL, Chen LY (1995) Identification of constitutive and inducable forms of nitric oxide synthase in human platelets. J Lab Clin Med

  38. 38.

    Radomski MW, Palmer RMJ, Moncada S (1987) The role nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148: 1482–1489

  39. 39.

    Sneddon JM, Vane JR (1988) Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci 85: 2800–2804

  40. 40.

    Alheid U, Reichwehr I, Forstermann U (1989) Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP. Eur J Pharmacol 164: 103–110

  41. 41.

    Balligand J-L, Unguranu D, Kelly RA, Kobzik L, Pimental D, Michel T, Smith TW (1993) Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91: 2314–2319

  42. 42.

    Shah AM, Spurgeon H, Sollott SJ, Talo A, Lakatta EG (1994) 8-Bromo cyclic GMP reduces the myofilament response to calcium in intact cardiac myocytes. Circ Res 74: 970–978

  43. 43.

    Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE (1993) Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265: H176-H182

  44. 44.

    Grocutt-Mason RM, Anning PB, Evans H, Lewis MJ, Shah AM (1994) Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 267: H1804-H1813

  45. 45.

    Paulus WJ, Vantrimpont PJ, Shah AM (1994) Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in man. Circulation 89: 2070–2078

  46. 46.

    Weyrich AS, Ma X-I, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicholas JM, Thomas AP, Lefer DJ, Vinten-Johansen J (1994) Physiologic concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res 75: 692–700

  47. 47.

    Kubes P (1992) Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 262: G1138-G1142

  48. 48.

    Payne D, Kubes P (1993) Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol 265: G189-G195

  49. 49.

    Kubes P (1993) Ischemia-reperfusion in the feline small intestine: a role for nitric oxide. Am J Physiol 264: G143-G149

  50. 50.

    Kanwar S, Wallace JL, Befus D, Kubes P (1994) Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 266: G222-G229

  51. 51.

    Salzman AL, Menconi MJ, Unno N, Ezzell RM, Casey DM, Gonzalez PK, Fink MP (1995) Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am J Physiol 268: G361-G373

  52. 52.

    Unno N, Menconi MJ, Smith M, Fink MP (1995) Nitric oxide mediates interferon-gamma-induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit Care Med 23: 1170–1176

  53. 53.

    Schneider F, Bucher B, Schott C, Andre A, Julou-Schaeffer G, Stoclet J-C (1994) Effect of bacterial lipopolysaccharide on function of rat small femoral arteries. Am J Physiol 266: H191-H198

  54. 54.

    Fleming I, Gray GA, Stoclet J-C (1993) Influence of endothelium on induction of thel-arginine-nitric oxide pathway in rat aortas. Am J Physiol 264: H1200-H1207

  55. 55.

    Brady AJB, Poole-Wilson PA, Harding SE, Warren JB (1992) Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263: H1963-H1966

  56. 56.

    Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387–389

  57. 57.

    Tepperman BL, Brown JF, Whittle BJR (1993) Nitric oxide synthase induction and intestinal cell viability in rats. Am J Physiol 265: G214-G218

  58. 58.

    Tepperman BL, Brown JF, Korol-kiewicz R, Whittle BJR (1994) Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: effect of endotoxin challange. J Pharmacol Exp Ther 271: 1477–1482

  59. 59.

    Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S (1994) Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 94: 2407–2413

  60. 60.

    Thiemermann C, Vane J (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182: 591–595

  61. 61.

    Kilbourn RG, Jubran GA, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF (1990) Reversal of endotoxin-mediated shock by NG-methyl-l-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132–1138

  62. 62.

    Meyer J, Traber LD, Nelson S, Lentz CW, Nakazawa H, Herndon DN, Noda H, Traber DL (1992) Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73: 324–328

  63. 63.

    Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28: 34–39

  64. 64.

    Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557–1558

  65. 65.

    Lorente JA, Landin L, de Pablo R, Renes E, Liste D (1993)l-Arginine pathway in the sepsis syndrome. Crit Care Med 21: 1287–1295

  66. 66.

    Preiser J-C, Lejeune P, Roman A, Carlier E, Backer DD, Leeman M, Kahn RJ, Vincent J-L (1995) Methylene blue administration in septic shock: a clinical trial. Crit Care Med 23: 259–264

  67. 67.

    Rosenberg SA, Lotze MT, Yang JC, Topalian SL, Chang AE, Schwartzentruber DJ, Aebersold P, Leitman S, Linehan WM, Seipp CA (1993) Prospective randomized trial of high-dose interleukin-2 alone or in combination with lymphokine-activate killer cells for the treatment of patients with advanced cancer. JNCI 85: 622–631

  68. 68.

    Teale DM, Atkinson AM (1992) Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 30: 839–842

  69. 69.

    Evans T, Carpenter A, Silva A, Cohen J (1994) Inhibition of nitric oxide synthase in experimental gramnegative sepsis. N Infect Dis 169: 343–349

  70. 70.

    Schultz PJ, Raij L (1992) Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 90: 1718–1725

  71. 71.

    Billiar TR, Curran RD, Harbrech BG (1990) Modulation on nitrogen oxide synthesis in vivo: NG-monomethyl-l-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 48: 565–569

  72. 72.

    Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, Billiar TR (1994) Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 266: G1004-G1010

  73. 73.

    Cobb JP, Natanson C, Hoffman WD, Lodato RF, Banks S, Koev CA, Solomon MA, Elin RJ, Hosseini JM, Danner RL (1992) Nw amino-l-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176: 1175–1182

  74. 74.

    Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR (1995) Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 114: 1666–1672

  75. 75.

    Barnard JW, Wilson PS, Moore TM, Thompson WJ, Taylor AE (1993) Effect of nitric oxide and cyclooxygenase products on vascular resistance in dog and rat lungs. J Appl Physiol 74: 2940–2948

  76. 76.

    Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA (1994) Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89: 2035–2040

  77. 77.

    Fineman JR, Crowley MR, Heymann MA, Soifer SJ (1991) in vivo attentuation of endothelium-dependent pulmonary vasodilation by methylene blue. J Appl Physiol 71: 735–741

  78. 78.

    Sprague RS, Thiemermann C, Vane JR (1992) Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits. Proc Natl Acad Sci 89: 8711–8715

  79. 79.

    Leeman M, de Beyl VE, Gilbert E, Melot C, Naeije R (1993) Is nitric oxide released in oleic acid lung injury. J Appl Physiol 74: 650–654

  80. 80.

    Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S (1991) Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 181: 852–857

  81. 81.

    Persson MG, Midtvedt T, Leone AM, Gustaffson LE (1994) Ca2+-dependent and Ca2+-independent exhaled nitric oxide, presence in germ-free animals, and inhibition by arginine analogues. Eur J Pharmacol 264: 13–20

  82. 82.

    Gerlach H, Rossaint R, Pappert D, Knorr M, Falke KJ (1994) Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 343: 518–519

  83. 83.

    Lundberg JON, Farkas-Szallasi T, Weitzberg E, Rinder J, Lindholm J, Änggärd A, Hökfelt T, Lundberg JM, Alving K (1995) High nitric oxide production in human paranasal sinuses. Nature Med 1: 370–373

  84. 84.

    Higenbottam TW, Pepke-Zaba J, Scott JP, Woolman P, Coutts C, Wallwork J (1988) Inhaled endothelium-derived relaxing factor in primary pulmonary hypertension (abstract). Am Rev Respir Dis 137: 107

  85. 85.

    Frostell CG, Fratacci MD, Wain JC Jr, Jones R, Zapol WM (1991) Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction (abstract). Circulation 83: 2038–2047

  86. 86.

    Fratacci MD, Frostell C, Chen T-Y, Wain JC, Jr., Robinson DR, Zapol WM (1991) Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 75: 990–999

  87. 87.

    Rossaint R, Falke KF, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399–405

  88. 88.

    Payen D, Gatecel C, Guinard N (1993) Inhalation of low dose of nitric oxide (NO) and IV L-arg in ARDS patients: effect on pulmonary, hemodynamic, gas exchange and NO metabolites (abstract). Am Rev Respir Dis 147: A720

  89. 89.

    Roberts JD, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818–819

  90. 90.

    Kinsella JP, Neish SR, Shaffer E, Abman SH (1992) Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 819–820

  91. 91.

    Kinsella JP, Abman SH (1993) Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatrics 91: 997–998

  92. 92.

    Gerlach H, Rossaint R, Pappert D, Falke KJ (1993) Time-course and doseresponse of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23: 499–502

  93. 93.

    Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ (1993) Longterm inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 19: 443–449

  94. 94.

    Puybasset L, Rouby JJ, Mourgeon E, Stewart TE, Cluzel P, Arthaud M, Poete P, Bodin L, Korinek AM, Viars P (1994) Inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med 20: 319–327

  95. 95.

    Naeije R, Lejeune P, Vachiery JL, Leeman M, Melot c, Hallemans R, Delcroix M, Brimioulle S (1990) Restored hypoxic pulmonary vasoconstriction by peripheral chemoreceptor agonists in dogs. Am Rev Respir Dis 142: 789–795

  96. 96.

    Melot c, Naieje R, Rotschild T, Mertens P, Mols P, Hallemans R (1983) Improvement in ventilation-perfusion matching by almitrine in COPD. Chest 83: 528–533

  97. 97.

    Reyes A, Roca J, Rodriguez-Roisin R, Torres A, Ussetti P, Wagner PD (1988) Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome. Am Rev Respir Dis 137: 1062–1067

  98. 98.

    Payen D, Gatecel C, Plaisance P (1993) Almitrine effect of nitric oxide inhalation in adult respiratory distress syndrome. Lancet 341: 1664

  99. 99.

    Hogman M, Frostell C, Arnberg H, Hedenstierna G (1993) Bleeding time prolongation and NO inhalation. Lancet 341: 1664–1665

  100. 100.

    Mercier J, Dehan M, Groupe Francais Pediatrique d'Etude du NO (1994) Inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Results of the French multicenter open study. (abstract). Am J Respir Crit Care Med 149: A475

  101. 101.

    Girard C, Lehot JJ, Pannetier JC, Filley S, French P, Estanove S (1992) Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 77: 880–883

  102. 102.

    Chollet-Martin S, Gatecel C, Payen D, Gougerot-Pocidalo M (1994) Effect of nitric oxide inhalation on cytokine production and polymorphonuclear neutrophil activation in the BAL fluid of patients with ARDS (abstract). Am Rev Respir Crit Care Med 149: A-567

  103. 103.

    Walmrath D, Schneider J, Pilch F, Grimminger W, Seeger W (1993) Aerosolized prostacyclin reduces pulmonary artery pressure and improves gas exchange in the adult respiratory distress syndrome (ARDS). Lancet 342: 961–962

Download references

Author information

Correspondence to M. P. Fink.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Fink, M.P., Payen, D. The role of nitric oxide in sepsis and ARDS: Synopsis of a roundtable conference held in Brussels on 18–20 March 1995. Intensive Care Med 22, 158–165 (1996). https://doi.org/10.1007/BF01720723

Download citation

Keywords

  • Oxide
  • Public Health
  • Nitric Oxide
  • Emergency Medicine
  • Roundtable Conference